Moderna has started human trials of an Omicron version of its COVID-19 vaccine SpikeVax, just in case a modified version will be needed to boost protection against the new variant later this year.

Moderna Inc. said Thursday a Phase 3 trial of ... which showed that mRNA-1283 had higher neutralizing antibody responses against both Omicron BA.4/5 and ancestral SARS-CoV-2 than mRNA-1273 ...

The UK has become the first country in the world to authorise an updated COVID-19 booster vaccine directed at the Omicron variant, giving a green light to Moderna's mRNA-1273.214 shot.

Concerns about the COVID-19 shots have increased after a report that drug maker Moderna failed to inform the U.S. government ...

Omicron: How worried should we be ... There was not enough data to analyse the Moderna or Janssen vaccines, but there is no reason to think they would have different results.

Moderna Inc. announced Tuesday that its next ... as it demonstrated a higher immune response against the Omicron BA.4/BA.5 ...

1 Omicron subvariant, which was prevalent last winter, and the original novel coronavirus strain that the previous vaccines were designed to fight. Pfizer Inc. and Moderna Inc. have each applied ...

a subvariant of the Omicron strain that includes EG.5 and BA.2.86. The vaccine, developed by Moderna Inc., will be administered from Sept.

The Omicron variant first was detected in late ... A week later, an EUA was issued for the Moderna mRNA vaccine. In large clinical trials, both vaccines were shown to be highly effective at ...

The XBB.1.5 subvariant — nicknamed ‘Kraken’ — is arguably the most genetically rich and most transmissible SARS-CoV-2 omicron subvariant yet. News Wrap: Russia shells Bakhmut in eastern ...